Liezl Krugmann

8PUBLICATIONS
20CO-AUTHORS
Gene and molecular therapyCheminformatics and quantitative structure-activity relationshipsPharmacogenomicsMolecular medicineBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 04, 2026
Repurposing Drugs for Malaria through a Human Dose Prediction: A Case Study with Berzosertib.

|Aug 28, 2024
Dose-fractionation studies of a Plasmodium phosphatidylinositol 4-kinase inhibitor in a humanized mouse model of malaria.

Liezl Gibhard, Mathew Njoroge, Mwila Mulubwa

|Apr 03, 2023
Integrating Pharmacokinetic-Pharmacodynamic Modeling and Physiologically Based Pharmacokinetic Modeling to Optimize Human Dose Predictions for Plasmodium falciparum Malaria: a Chloroquine Case Study.

Devasha Redhi, Mwila Mulubwa, Liezl Gibhard

|Mar 31, 2023
A Water-Soluble Polymer-Lumefantrine Conjugate for the Intravenous Treatment of Severe Malaria.

William M R Matshe, Lesego L Tshweu, Sindisiwe Mvango

|Mar 10, 2022
Spiropyrimidinetriones: a Class of DNA Gyrase Inhibitors with Activity against Mycobacterium tuberculosis and without Cross-Resistance to Fluoroquinolones.

Gregory S Basarab, Sandeep Ghorpade, Liezl Gibhard

|Sep 26, 2018
Investigating Sulfoxide-to-Sulfone Conversion as a Prodrug Strategy for a Phosphatidylinositol 4-Kinase Inhibitor in a Humanized Mouse Model of Malaria.

Liezl Gibhard, Mathew Njoroge, Tanya Paquet

Pageof 2

Frequent Collaborators

3 joint publications

Gregory S Basarab

1 joint publications

Dina Coertzen

1 joint publications

Lyn-Marie Birkholtz

1 joint publications

Gregory Thomas Robertson